Skip to main content
$131.53 -$2.68 (-2.0%)

04:00 PM EDT on 10/22/21

Intellia Therapeutics, Inc. (NASDAQ:NTLA)

CAPS Rating: 4 out of 5

Current Price $131.53 Mkt Cap $9.9B
Open $133.64 P/E Ratio 0.00
Prev. Close $131.53 Div. (Yield) $0.00 (0.0%)
Daily Range $129.50 - $135.14 Volume 450,181
52-Wk Range $23.49 - $202.73 Avg. Daily Vol. 803,213

Caps

How do you think NASDAQ:NTLA will perform against the market?

Add Stock to CAPS Watchlist

All Players

130 Outperform
4 Underperform
 

All-Star Players

43 Outperform
1 Underperform
 

Wall Street

0 Outperform
0 Underperform
 

Top NASDAQ:NTLA Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

TMFbonefish (54.49)
Submitted May 05, 2021

It's hard not to imagine gene-editing as the future of medicine. The company has about $600 million in cash and short-term investments on its balance sheet, and recently received funding from the Bill & Melinda Gates Foundation. That cash cushion is… More

Top Bear Pitch

There are no pitches that meet the Top Bear criteria. Explain

If this upsets you, start recommending pitches below!

NASDAQ:NTLA VS S&P 500 (SPY)

NASDAQ:NTLA Summary

Fools bullish on NASDAQ:NTLA are also bullish on:

Fools bearish on NASDAQ:NTLA are also bearish on:

Recent Community Commentary

Read the most recent pitches from players about NTLA.

Recs

0
Member Avatar TMFRetireFoolish (< 20) Submitted: 7/8/2021 1:22:52 AM : Outperform Start Price: $151.10 NASDAQ:NTLA Score: -19.26

CRSPR in vivo success would position for many new therapies and industry leadership

Recs

1
Member Avatar TMFbonefish (54.49) Submitted: 5/5/2021 5:06:08 PM : Outperform Start Price: $72.96 NASDAQ:NTLA Score: +70.01

It's hard not to imagine gene-editing as the future of medicine. The company has about $600 million in cash and short-term investments on its balance sheet, and recently received funding from the Bill & Melinda Gates Foundation. That cash cushion is important. Even if the company eventually delivers a treatment or treatments that lead to commercial success, that won't happen for a least a few years. For investors, therefore, owning Intellia stock requires a leap of faith.

Recs

0
Member Avatar CBK (50.73) Submitted: 4/23/2021 8:55:49 AM : Outperform Start Price: $70.36 NASDAQ:NTLA Score: +75.84

Finishing Walter Isaacson's The Code Breaker has made me believe that the next revolution that we are living in is the genomic revolution. Companies like Illumina, Editas, Crispr, Moderna, and Intellia are powering this revolution.

Leaderboard

Find the members with the highest scoring picks in NTLA.

Score Leader

birdup

birdup (25.56) Score: +1,135.01

The Score Leader is the player with the highest score across all their picks in NTLA.

Top
Pick
Member Name Member
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
Index
Gain
Score Commentary
birdup 25.56 3/16/2020 Outperform 5Y $9.87 +1,223.05% +88.04% +1,135.01 0 Comment
Playa14 < 20 10/17/2019 Outperform 5Y $11.40 +1,045.48% +51.66% +993.82 0 Comment
TraderEnvy < 20 10/4/2019 Outperform 5Y $11.94 +993.68% +55.56% +938.11 0 Comment
clangmead 54.02 12/28/2018 Outperform 5Y $12.51 +943.84% +82.27% +861.58 0 Comment
CMFMLove 74.90 6/13/2017 Outperform 5Y $12.67 +930.66% +85.73% +844.93 1 Comment
This player feels very strongly about this pick and has marked it a Top Pick. Top Picks do not affect a player’s score. ldigout 98.56 4/13/2020 Outperform 5Y $13.05 +900.65% +63.38% +837.27 0 Comment
Kevinkress 87.68 5/4/2020 Outperform 5Y $13.09 +897.59% +61.43% +836.16 0 Comment
ZabasJ 83.04 4/21/2020 Outperform 5Y $13.33 +879.61% +65.10% +814.51 0 Comment
prankjt17530 61.19 2/13/2017 Outperform 5Y $13.02 +902.96% +95.26% +807.70 0 Comment
steveo23 90.47 4/21/2020 Outperform 5Y $13.45 +870.89% +63.72% +807.17 0 Comment

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

There are no Wall Street tracker picks for NTLA.